Celldex Therapeutics (CLDX) Gross Profit (2010 - 2026)

Celldex Therapeutics (CLDX) posted quarterly Gross Profit of -$1.4 million for Q1 2026, up 2.04% year-over-year from -$1.4 million in Q1 2025, and down 30.35% quarter-over-quarter from -$1.1 million in Q4 2025.

Celldex Therapeutics (CLDX) Gross Profit (2010 - 2026) Analysis & Trends

Celldex Therapeutics' Gross Profit history runs 7 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

  • In Q1 2026, Gross Profit rose 2.04% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$4.4 million (down 506.34% YoY), while the FY2025 annual figure was -$4.5 million, down 415.97% from the prior year.
  • Gross Profit for Q1 2026 stood at -$1.4 million, down from -$1.1 million in the prior quarter.
  • The five-year high for Gross Profit was $2.1 million in Q3 2024, with the low at -$1.5 million in Q1 2025.
  • The 3-year median for Gross Profit is -$1.1 million (2025), against an average of -$498333.3.
  • The sharpest annual moves came in 2025 and 2026: Gross Profit plunged 192.19% in 2025, then grew 2.04% in 2026.
  • Celldex Therapeutics' Gross Profit stood at -$439000.0 in 2024, then tumbled by 152.16% to -$1.1 million in 2025, then tumbled by 30.35% to -$1.4 million in 2026.
  • Business Quant data shows CLDX's Gross Profit at -$1.4 million in Q1 2026, -$1.1 million in Q4 2025, and -$1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Celldex Therapeutics 3.29 Bn 2.58 Bn -2.57 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.57 Mn
Jun 30, 2026 -2.57 Mn
Mar 31, 2026 -1.44 Mn
Mar 31, 2026 -1.44 Mn
Dec 31, 2025 -1.11 Mn
Dec 31, 2025 -1.11 Mn
Sep 30, 2025 -1.06 Mn
Sep 30, 2025 -1.06 Mn
Jun 30, 2025 -814,000.00
Jun 30, 2025 -814,000.00
Mar 31, 2025 -1.47 Mn
Mar 31, 2025 -1.47 Mn
Dec 31, 2024 -439,000.00
Dec 31, 2024 -439,000.00
Sep 30, 2024 2.12 Mn
Sep 30, 2024 2.12 Mn
Jun 30, 2024 883,000.00
Jun 30, 2024 883,000.00
Mar 31, 2024 -1.15 Mn
Mar 31, 2024 -1.15 Mn